Leflunomide for active rheumatoid arthritis

Clinical Trial

G F Ferraccioli et al. Lancet. 1999.

. 1999 May 29;353(9167):1883; author reply 1883-4.

doi: 10.1016/s0140-6736(05)75089-3.

No abstract available

Comment on

Outstanding issues in use of disease-modifying agents in rheumatoid arthritis.
Madhok R, Capell HA. Madhok R, et al. Lancet. 1999 Jan 23;353(9149):257-8. doi: 10.1016/s0140-6736(05)74938-2. Lancet. 1999. PMID: 9929016 No abstract available.
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R. Smolen JS, et al. Lancet. 1999 Jan 23;353(9149):259-66. doi: 10.1016/s0140-6736(98)09403-3. Lancet. 1999. PMID: 9929017 Clinical Trial.